Clinical Trials Logo

Labor Induction clinical trials

View clinical trials related to Labor Induction.

Filter by:

NCT ID: NCT00886860 Completed - Cervical Ripening Clinical Trials

The Comparison of Efficacy for Cervical Ripening in Labor Induction Between Titrated and Conventional Oral Misoprostol

Start date: May 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the efficacy for cervical ripening in labor induction between titrated and conventional oral misoprostol

NCT ID: NCT00529295 Completed - Labor Induction Clinical Trials

Titrated Oral Compared With Vaginal Misoprostol for Labor Induction at Term

Start date: June 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study was to estimate the safety and efficacy of titrated oral misoprostol compared with vaginal route for labor induction at term.

NCT ID: NCT00504465 Completed - Cervical Ripening Clinical Trials

Combined Agent Randomized Trial of Induction of Labor

Start date: May 2002
Phase: N/A
Study type: Interventional

To compare sequential dinoprostone and oxytocin for induction of labor at term with intact membranes and an unripe cervix to two simultaneous regimens. Our aim was to confirm findings from smaller trials and add to data on fetal safety.

NCT ID: NCT00442663 Completed - Cervical Ripening Clinical Trials

Trial of Foley Catheter With and Without Extra-Amniotic Saline Infusion for Labor Induction

FOLEYEASI
Start date: June 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the efficacy of a transcervical Foley catheter with and without extra-amniotic saline infusion (EASI) for priming the cervix for labor.

NCT ID: NCT00346840 Completed - Cervical Ripening Clinical Trials

Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour

Start date: June 2003
Phase: Phase 2
Study type: Interventional

The primary objective of the study was assessment of the efficacy of four dose reservoirs (25 mcg, 50 mcg, 100 mcg, 200 mcg) of intravaginal controlled release misoprostol administered for up to 24 hours. Efficacy was measured in terms of time from insert placement to vaginal delivery.